by Commetric | Jul 23, 2026 | Uncategorized
For years, the conversation around GLP‑1 obesity medicines has been dominated by clinical efficacy, patient outcomes and soaring demand. The announcement of the Medicare GLP‑1 Bridge Program marks a turning point. The discussion is shifting from whether GLP‑1...
by Commetric | Jun 19, 2026 | Blog
Commetric has been recognised with two awards at the 2026 DataComms Awards, hosted by Communicate Magazine, underscoring the impact of its innovative approach to communications measurement and reputation intelligence. Working in partnership with Novartis, Commetric...
by Commetric | Apr 30, 2026 | Blog
Peptides are rapidly emerging as one of the most complex and contested topics in healthcare today, spanning cutting-edge oncology, metabolic disease, and an expanding grey zone of consumer-led experimentation. For communications leaders in pharma...
by Commetric | Apr 28, 2026 | Newsroom
Commetric has been shortlisted in two categories at the 2026 DataComms Awards, hosted by Communicate Magazine / Cravenhill Puiblishing, recognising work that moves communications measurement beyond outputs and towards demonstrable business impact. The shortlisted...
by Commetric | Mar 12, 2026 | Blog
A Q&A with Commetric’s Director of Data Engineering, Alexander Belokapov Artificial intelligence is rapidly transforming how organisations analyse media narratives, reputational risks, and stakeholder influence. But with growing AI capabilities comes the need for...
